Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 30 of 57 found articles
 
 
  MYC/BCL2 Protein Co-Expression Defines a Unique Subset of Aggressive Lymphoma and Contributes to the Inferior Prognosis of Activated B-cell Subtype of Diffuse Large B-cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study
 
 
Title: MYC/BCL2 Protein Co-Expression Defines a Unique Subset of Aggressive Lymphoma and Contributes to the Inferior Prognosis of Activated B-cell Subtype of Diffuse Large B-cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study
Author: Hu, Shimin
Xu-Monette, Zijun Y.
Wu, Lin
Visco, Carlo
Tzankov, Alexander
Montes-Moreno, Santiago
Dybkær, Karen
Chiu, April
Orazi, Attilio
Zu, Youli
Bhagat, Govind
Richards, Kristy L.
Hsi, Eric D.
Zhao, X. Frank
Choi, William W.L.
Zhao, Xiaoying
Zhang, Xiaohong
Han van Krieken, J.
Huang, Qing
Huh, Jooryung
Ai, Weiyun
Ponzoni, Maurilio A.
Ferreri, Andres J.M.
Zhou, Fan
Winter, Jane N.
Go, Ronald S.
Li, Yong
Piris, Miguel A.
Møller, Michael B.
Miranda, Roberto N.
Medeiros, L. Jeffrey
Young, Ken H.
Appeared in: Clinical lymphoma myeloma and leukemia
Paging: Volume 13 (2013) nr. S2 pages 2 p.
Year: 2013
Contents:
Publisher: Published by Elsevier B.V.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 30 of 57 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands